DrugPatentWatch Database Preview
Drugs in MeSH Category Reverse Transcriptase Inhibitors
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo | NEVIRAPINE | nevirapine | TABLET;ORAL | 077521-001 | May 22, 2012 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| Lupin Ltd | LAMIVUDINE | lamivudine | TABLET;ORAL | 205217-002 | Dec 18, 2014 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| Aurobindo Pharma Ltd | NEVIRAPINE | nevirapine | TABLET, EXTENDED RELEASE;ORAL | 207698-001 | Feb 28, 2017 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-001 | Jun 19, 1992 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
